Fink JK - Search Results

1

Albers JW, Fink JK. Albers JW, et al. Among authors: fink jk. Muscle Nerve. 2004 Oct;30(4):410-22. doi: 10.1002/mus.20137. Muscle Nerve. 2004. PMID: 15372536 Free article. Review.

2

Neuropathy target esterase gene mutations cause motor neuron disease.

Rainier S, Bui M, Mark E, Thomas D, Tokarz D, Ming L, Delaney C, Richardson RJ, Albers JW, Matsunami N, Stevens J, Coon H, Leppert M, Fink JK. Rainier S, et al. Among authors: fink jk. Am J Hum Genet. 2008 Mar;82(3):780-5. doi: 10.1016/j.ajhg.2007.12.018. Epub 2008 Feb 28. Am J Hum Genet. 2008. PMID: 18313024 Free PMC article.

3

Motor neuron disease due to neuropathy target esterase gene mutation: clinical features of the index families.

Rainier S, Albers JW, Dyck PJ, Eldevik OP, Wilcock S, Richardson RJ, Fink JK. Rainier S, et al. Among authors: fink jk. Muscle Nerve. 2011 Jan;43(1):19-25. doi: 10.1002/mus.21777. Muscle Nerve. 2011. PMID: 21171093 Free article.

4

Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working group.

Fink JK, Heiman-Patterson T, Bird T, Cambi F, Dubé MP, Figlewicz DA, Fink JK, Haines JL, Heiman-Patterson T, Hentati A, Pericak-Vance MA, Raskind W, Rouleau GA, Siddique T. Fink JK, et al. Neurology. 1996 Jun;46(6):1507-14. doi: 10.1212/wnl.46.6.1507. Neurology. 1996. PMID: 8649538 Review.

5

Approach to patients with inherited neurologic disorders.

Fink JK. Fink JK. Semin Neurol. 1998;18(2):211-9. doi: 10.1055/s-2008-1040874. Semin Neurol. 1998. PMID: 9608618 Review.

6

Neuropathy target esterase (NTE): overview and future.

Richardson RJ, Hein ND, Wijeyesakere SJ, Fink JK, Makhaeva GF. Richardson RJ, et al. Among authors: fink jk. Chem Biol Interact. 2013 Mar 25;203(1):238-44. doi: 10.1016/j.cbi.2012.10.024. Epub 2012 Dec 3. Chem Biol Interact. 2013. PMID: 23220002 Review.

7

Rare treatable neurologic diseases.

Lorincz MT, Fink JK. Lorincz MT, et al. Among authors: fink jk. Semin Neurol. 2012 Nov;32(5):489-90. doi: 10.1055/s-0033-1334480. Epub 2013 May 15. Semin Neurol. 2012. PMID: 23677655 No abstract available.

8

Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients.

Brewer GJ, Dick RD, Johnson V, Wang Y, Yuzbasiyan-Gurkan V, Kluin K, Fink JK, Aisen A. Brewer GJ, et al. Among authors: fink jk. Arch Neurol. 1994 Jun;51(6):545-54. doi: 10.1001/archneur.1994.00540180023009. Arch Neurol. 1994. PMID: 8198464

9

Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy.

Brewer GJ, Hedera P, Kluin KJ, Carlson M, Askari F, Dick RB, Sitterly J, Fink JK. Brewer GJ, et al. Among authors: fink jk. Arch Neurol. 2003 Mar;60(3):379-85. doi: 10.1001/archneur.60.3.379. Arch Neurol. 2003. PMID: 12633149 Clinical Trial.

10

Hereditary spastic paraplegia.

Fink JK. Fink JK. Curr Neurol Neurosci Rep. 2006 Jan;6(1):65-76. doi: 10.1007/s11910-996-0011-1. Curr Neurol Neurosci Rep. 2006. PMID: 16469273 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page